First a quick description (Source: Yahoo Finance):
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, engages in the acquisition, development and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome.
The drugs Cumberland has on the market were responsible for the following distribution of revenues in the latest...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|